Saturday, April 16, 2016 4:36:00 PM
There were 10 RECIST complete or partial responses (CR/PR) out of 37 (15 BRCA m) evaluable pts, including gBRCA m breast (n=4), platinum-resistant gBRCA m ovarian (n=2), BRCA wildtype (WT) triple negative breast (n=1), BRCA WT ovarian (n=2) and BRCA unknown prostate (n=1) cancer pts.
http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=4017&sKey=946fbd6f-3560-4ea2-aed6-7788155ea81b&cKey=fbf921a7-552a-44ee-aa04-a345ece10ad8&mKey=1d10d749-4b6a-4ab3-bcd4-f80fb1922267
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM